Feeding very small premature infants with concentrated breast milk

The use of concentrated breast milk was prospectively studied in 26 very small premature babies with a birth weight of 1,010-1,500 g. 57 premature babies of the same birth weight group born in the two preceding years and fed normal pooled breast milk served as a control group. Fresh breast milk was enriched using lyophilized breast milk yielding a calory content of 103 cal/100 ml. Early intermittent nasogastric feeding using this milk enabled full oral calory supply from the 5th day on. 130 ml/kg/day of enriched breast milk yields 134 cal/kg per day with somewhat less fat but more protein (2.8 g/kg vs 2.2 g/kg) and sodium (1.9 mmol vs 1.5 mmol) than 200 ml/kg/day of ordinary breast milk. About 50% of the study patients and the control group needed intensive care with mechanical ventilation. Mortality was 15% and 28%, respectively. Necrotizing enterocolitis was rare in both groups (3.3 vs 3.5%). Due to extragastric complications oral feeding had to be reduced in 18% (study group) and in 27% (ordinary breast milk), the most frequent indication was a patent ductus arteriosus with heart insufficiency. Postnatal weight gain was comparatively good with a mean increment of 112 g in the second and 150 g in the third week. Growth of body length during the first three weeks was on average 0.72 cm/week, head circumference increased 0.57 cm/week. However, in the control group similar results were noted. During the second week of life patients fed concentrated breast milk had somewhat higher plasma sodium und urea values.(ABSTRACT TRUNCATED AT 250 WORDS)     

Growth of very low birth-weight Indian infants during hospital stay

Objectives  

To evaluate the growth pattern of Very Low Birth Weight (VLBW) infants (birthweight <1500g) during hospital stay and to compare the growth of Small for gestational age (SGA) and Appropriate for gestational age (AGA) infants.     

Early cessation of breast milk feeding in very low birthweight infants

This investigation was carried out to comparatively assess the duration of breast milk feeding and to analyze risk factors for early cessation of breast milk feeding in term and very preterm infants. A cohort study was performed in 89 consecutive very low birthweight (VLBW) infants (<1500 g) who survived for at least for one week, and 177 term infants with birthweights >2500 g born in the same hospital matched for gender and multiplicity. Median duration of breast milk feeding, as determined from charts and questionnaires mailed to the mothers at 6 and 12 months corrected age, was 36 days in VLBW infants, compared to 112 days in control infants (P<0.0001). In both VLBW and control infants, smoking during pregnancy, low maternal and low paternal school education were each significantly associated with short duration of breast milk feeding. In VLBW infants, multiple pregnancy and gestational age <29 weeks were each associated with prolonged breast milk feeding, as were maternal age >35 years and spontaneous pregnancy (as opposed to pregnancy following infertility treatment) in term infants. Multivariate analysis revealed that VLBW, smoking and low parental school education were independent negative predictors of breast milk feeding. While these results emphasize the need for special support of VLBW infant mothers promoting lactation, the relationships between smoking, school education and breast milk feeding in both strata show that efforts to increase breast milk feeding require a public health perspective.     

Breast milk and breast feeding in very low birthweight infants.

The feeding of 17 babies weighing less than 1500 g was examined retrospectively. 12 babies started breast feeding at a mean weight of 1324 g and 10 of them were fully breast fed by a mean weight of 1600 g. Their weight gains were comparable with bottle-fed babies receiving expressed breast milk. Practical aspects of breast feeding were considered to be: a knowledgeable maternal and nursing attitude, close mother and baby contact, early expression of breast milk, and early suckling. The increased incidence of breast feeding by mothers of both low birthweight and term babies ensures regular supplies of fresh breast milk. Therefore, sterilisation or storage of breast milk there is unnecessary.     

Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants

The aim of this study was to compare two different doses and means of administration of iron in recombinant human erythropoietin (rHuEPO)-treated very low birth-weight (VLBW) infants. VLBW infants (n = 41) were randomized to one of three groups. Fourteen infants were treated with rHuEPO (300 IU/kg three times a week s.c.) and oral iron (ferrofumarate, 6 mg of iron/kg per day). Another 14 infants received the same erythropoietin dose and intramuscular iron (ferroxypolymaltose, once 12 mg of iron/kg weekly). Thirteen infants were treated with the same dose of intramuscular iron but did not receive rHuEPO. After the 3-week study period, haemoglobin concentrations and reticulocyte counts were similar in the rHuEPO-treated groups and both were higher than in the group not receiving rHuEPO (P < 0.001). In both rHuEPO-treated groups the transferrin receptor concentration increased from 6.8–7.2 mg/l to 10.5–11.3 mg/l. Conclusion In erythropoietin-treated very low birth weight infants the iron need for erythropoiesis can be met by oral administration of iron. Received: 17 November 1997 and in revised form: 6 March 1998 / Accepted: 30 April 1998     

Effects of different levels of intravenous alpha-linolenic acid and supplemental breast milk on red blood cell docosahexaenoic acid in very low birth-weight infants.

Preterm infants weighing less than 1,500 g were started on total parenteral nutrition (TPN) if unable to tolerate full enteral feedings. They were randomly assigned to receive intravenous lipids containing either 4.2 or 9.0% alpha-linolenic acid to assess the effect on red blood cell (RBC) phospholipid polyenoic fatty acid composition, particularly docosahexaenoic acid (22:6n3) (DHA). DHA ultimately comes from alpha-linolenic acid (18:3n3), although there is evidence in human preterm infants that they require preformed DHA. After 1 week of TPN, infants were started on gradually increasing amounts of enteral feeding, breast milk, if elected by mothers, or premature milk formula (Preemie Enfamil). RBC phospholipid fatty acids were measured weekly. Results were evaluated comparing samples from week 1 and week 6. Supplying 9% alpha-linolenic acid in intravenous lipids did not prevent a fall in DHA by 6 weeks; however, infants receiving breast-milk feeding did not have a significant decrease in DHA. Studies are needed to evaluate supplying DHA in intravenous lipids.     

母乳强化剂在极低出生体质量儿母乳喂养中的应用

<正>随着二胎政策实施和辅助生殖技术的发展,高龄产妇和试管婴儿出生率逐渐升高,早产儿的出生率不断上升,2016年国内15家医疗机构的现状调查发现,早产发生率为9.9%,其中出生胎龄(gestational age,GA)28周占2. 3%,28～34周占22. 7%~([1])。母乳是早产儿的最佳食物,其较于配方奶存在营养、免疫、生长发育、心理、社会、经济等方面优势。然而,纯母     

Changes in growth and metabolism in very low birthweight infants fed with fortified breast milk

Human milk is often inadequate nutritionally for preterm infants. We investigated the effect of adding a commercially prepared milk fortifier to human (maternal or bank) milk and measured changes in lower leg length velocity (LLLvel) using knemometry, weight gain and biochemical indices of nutrition. Babies were allocated to one of three feed groups, in a semi-randomized fashion, to receive human milk alone (group I), fortified human milk (group II) or a preterm formula (group III). The birthweights (median and R) and birth gestations (median and R) of the three groups were as follows: group I 1099 g (654-1248 g) and 28 wk (26-32 wk); group II 838 g (742-1340g) and 31 wk (28-36); group III 1136g (624-1552g) and 32 wk (27-36 wk). All babies who received fortified milk either showed significant (p = 0.0004) acceleration in LLLvel during the period studied, or maintained their pre-study period velocity. This increase in LLLvel was comparable to that achieved by a group of babies given a standard preterm infant formula (p < 0.001). By comparison, the control group's change in LLLvel was more modest (p = 0.04). Babies who received human milk with the fortifier added had the lowest serum levels of alkaline phosphatase at the end of the study period when compared to the other two groups. Other biochemical indices were similar in the three feed groups. No adverse clinical events were encountered which could be attributed to the use of the breast milk fortifier.     

Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus

Indomethacin has proven effective in closing the patent ductus arteriosus (PDA) in most low birth weight (LBW) neonates with this disorder. Early reopening of the ductus is a problem and often leads to the need for surgery. Prolonged use of indomethacin for several days has been suggested as a means to alleviate this problem. The present study was designed to determine if prolonged therapy over 5 days is more effective than a two-dose regimen in preventing reopening of the PDA. Seventy neonates were randomized for either prolonged therapy over 1 week or to receive two doses of indomethacin. All infants were given two doses of indomethacin 0.15 mg per kg, 12 h apart. The maintenance group received an additional 0.1 mg per kg daily for 5 days. Ten days after the infants' initial dose of indomethacin, 6 of 22 in the nonmaintenance group as compared to 0 of 22 in the maintenance group had reopening of their ductus arteriosus. Ten infants in the maintenance group eventually had the ductus reopen at a median of 29, range 11–66 days compared to a median of 3, range 2–44 days in the nonmaintenance group. Significantly fewer babies in the maintenance group had a grade II–IV intraventricular hemorrhage compared to the nonmaintenance group. There was no other significant difference in the two groups in the incidence of necrotizing enterocolitis, retrolental fibroplasia or death. Indomethacin given over 5 days is effective for closure of the ductus arteriosus and will prevent reopening until after the acute clinical course in babies under 1500 g; however, the overall incidence of reopening was not different.Abbreviations HMD hyaline membrane disease - IVH intraventricular hemorrhage - NICU neonatal intensive care unit - NIH National Institutes of Health - PDA patent ductus arteriosus - LBW low birht weight - VLBW very low birth weight (less than 1500 g)     

周围中心静脉导管在极低体重儿运用的临床对照观察

目的　探讨经皮插入中心静脉导管 (PICC)在极低体重儿 (VLBW )运用的临床价值。方法　采用经皮插入中心静脉导管治疗 40例极低体重儿 ,并与同期运用外周静脉穿刺术 (PIV)治疗的 3 7例极低体重儿进行临床观察。结果　PICC组与PIV组比较 :穿刺次数、住院时间减少 ,结果具有显著性差异 ;静脉运用时间、血培养阳性率及病死率无显著性差异。入院 3 0d两组体重比较 ,结果具有显著性差异 ;两组肝功能、肾功能、血电解质、血脂异常及高血糖的发生率无显著性差异 ,而低血糖的发生率具有显著性差异 ;PICC组 40例拔管的原因 ,其中不再需要 2 1例、感染 5例、机械并发症 6例、死亡 4例及其它 4例。结论　PICC可以方便的提供极低体重儿静脉营养 ,顺利过渡到胃肠道喂养 ;PICC减少了极低体重儿静脉穿刺的次数 ,从而减少人为的过度刺激 ,降低氧和能量的消耗 ;PICC可以使极低体重儿体重增长迅速 ,减少住院时间 ,而并发症的发生率低     

Breast milk feeding in very low birthweight infants

ABSTRACT. The infant feeding practices of 77 very low birthweight (VLBW) survivors with birthweights under 1500 g were studied. 58 (75%) infants received fresh expressed breast milk (EBM) from their own mothers, of whom 42 were successfully breastfed at a medium postconceptual age of 36 weeks. Overall incidence of breastfeeding in the VLBW population was 44% at 3 months and 23% at 6 months. The postnatal ages at which breastfeeding stopped ranged from 2 months to 28 months (median 4 months). No significant differences in perinatal factors were found between the breast milk and milk formula groups. There were significantly more mothers in the breast milk group who were given advice and encouragement during their pregnancy on breastfeeding and who had planned in the antenatal period to breastfeed their infants. The most common reasons given for deciding against providing breast milk were related to extreme prematurity of the infant. Nursery weight gain of infants fed breast milk and milk formula were similar. Necrotizing enterocolitis occurred significantly less frequently in the breast milk group. The study suggested that the special attention and positve encouragement given to parents of VLBW infants had contributed to the successful establishment and continuation of a feeding regime utilizing fresh breast milk from the infant's own mother, which we believe has immunological, psychological and nutritional benefits in this high-risk infant population.     

Suppressive effects of breast milk on oxidative DNA damage in very low birthweight infants

BACKGROUND: Human milk contains many kinds of antioxidant and is considered to prevent diseases mediated by oxygen free radicals in very low birthweight (VLBW) infants. AIMS: To examine the antioxidant effects of breast milk in VLBW infants by determining urinary 8-hydroxydeoxyguanosine (8-OHdG) excretion, which is known to be a non-invasive marker for in vivo oxidative DNA damage. METHODS: Urinary 8-OHdG concentrations were measured in 15 breast fed and 14 formula fed VLBW infants at 2, 7, 14, and 28 days of age. RESULTS: Urinary 8-OHdG excretion at 14 and 28 days of age was significantly lower than at 2 and 7 days of age in the breast fed group, and significantly lower than in the formula fed group. CONCLUSION: This is the first direct evidence of the antioxidant action of human milk in VLBW infants.     

Bone growth with low bone mineral content in very low birth weight premature infants

We report serial measurements of bone mineral content (BMC), bone width (BW, a measure of appositional bone growth), and the ratio of BMC:BW by photon absorptiometry of the left radius through the first 10 wk of life in 38 very low birth weight premature infants (birth weight less than 1300 g, gestational age less than 32 wk). Fifteen of 38 infants developed bronchopulmonary dysplasia (BPD) and as a group they could not be distinguished from the 23 infants without BPD, despite the high association between BPD and metabolic bone disease. As BPD occurred in the smaller patients, the BPD group had a significantly lower mean birth weight and mean gestational age as compared to controls (950 +/- 125 g versus 1119 +/- 149, and 28.0 +/- 0.8 versus 29.0 +/- 1.3 wk). For both control and BPD groups, BMCs did not differ and remained relatively unchanged throughout the first 10 wk of life, lagging significantly behind the intrauterine rate as defined by measuring BMC in 175 infants of varying gestational ages during the first few days of life. BW also did not differ during this period between groups. BW did increase significantly in both groups (from 3.2 +/- 0.3 to 3.9 +/- 0.4 mm in the controls and from 3.0 +/- 0.3 to 3.8 +/- 0.4 mm in the BPD group), but remained significantly delayed compared to the intrauterine rate. In both groups, BMC remained relatively constant despite increasing BW and thus BMC/BW decreased during the first 10 wk of life (from 11.5 +/- 1.3 to 10.2 +/- 1.9 in the controls and from 11.0 +/- 1.3 to 8.6 +/- 2.2 in the BPD group).(ABSTRACT TRUNCATED AT 250 WORDS)     

Nutrition and growth analysis of very low birth weight infants

The growth and nutrition of 220 very low birth weight infants were reviewed after comprehensive data on all infants in the hospital were entered into the Neonatal Intensive Care Unit Audit Data Base for 2 years prospectively. Fluid and energy (parenteral and oral) intakes were compared in four birth weight categories (1, less than or equal to 750 g; 2, 751 to 1000 g; 3, 1001 to 1250 g; 4, 1251 to 1500 g). Parenteral nutrition was the major source of first nutrition for the small infants, but seldom did it alone provide adequate nutrition for very low birth weight infants. The age of the first nutrition (parenteral and/or oral nutrition other than dextrose) decreased with increasing birth weight. The age of the first oral feedings was later for the infants of the lower birth weights but enteral feeding became the major nutrition for all weight categories by the second week of life. During the first 50 days the infants accumulated a deficit of 3780 to 5460 kJ relative to their estimated need of 504 kJ/kg per day, with the smaller infants accumulating a significantly larger deficit. The growth of infants appropriate for gestational age and of infants small for gestational age differed from each other and from the commonly used graph of Dancis et al (J Pediatr. 1948;33:570-572).